Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription
Read More
Biotech and Pharmaceuticals
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |
Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a
Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from
Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.
Read More
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster
Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and
Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a
Read More
Moderna says FDA refuses to review its application for experimental flu shot
The Food and Drug Administration has refused to start a review of Moderna’s application for its experimental flu shot, the
Read More